A detailed history of Parallel Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Parallel Advisors, LLC holds 121,325 shares of ABT stock, worth $14.1 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
121,325
Previous 122,069 0.61%
Holding current value
$14.1 Million
Previous $12.7 Million 9.05%
% of portfolio
0.33%
Previous 0.33%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $74,452 - $87,888
-744 Reduced 0.61%
121,325 $13.8 Million
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $172,953 - $193,059
1,717 Added 1.43%
122,069 $12.7 Million
Q1 2024

May 06, 2024

BUY
$109.52 - $120.96 $334,364 - $369,290
3,053 Added 2.6%
120,352 $13.7 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $142,770 - $174,763
-1,583 Reduced 1.33%
117,299 $12.9 Million
Q3 2023

May 20, 2024

SELL
$95.53 - $114.62 $86,454 - $103,731
-905 Reduced 0.76%
118,882 $11.5 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $86,454 - $103,731
-905 Reduced 0.76%
118,882 $11.5 Million
Q2 2023

May 20, 2024

BUY
$100.78 - $112.29 $138,370 - $154,174
1,373 Added 1.16%
119,787 $13.1 Million
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $138,370 - $154,174
1,373 Added 1.16%
119,787 $13.1 Million
Q1 2023

May 20, 2024

SELL
$96.86 - $114.01 $187,714 - $220,951
-1,938 Reduced 1.61%
118,414 $12 Million
Q1 2023

Apr 25, 2023

BUY
$96.86 - $114.01 $8.31 Million - $9.78 Million
85,811 Added 263.2%
118,414 $12 Million
Q4 2022

Feb 03, 2023

SELL
$95.06 - $111.52 $61,789 - $72,488
-650 Reduced 1.95%
32,603 $3.58 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $166,523 - $192,803
1,721 Added 5.46%
33,253 $3.22 Million
Q2 2022

Aug 01, 2022

BUY
$102.07 - $123.37 $311,109 - $376,031
3,048 Added 10.7%
31,532 $3.43 Million
Q1 2022

Apr 28, 2022

SELL
$114.02 - $139.04 $427,575 - $521,399
-3,750 Reduced 11.63%
28,484 $3.43 Million
Q4 2021

Jan 20, 2022

BUY
$115.53 - $141.46 $155,041 - $189,839
1,342 Added 4.34%
32,234 $4.54 Million
Q3 2021

Nov 02, 2021

BUY
$116.66 - $129.06 $561,367 - $621,036
4,812 Added 18.45%
30,892 $3.65 Million
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $149,481 - $175,960
-1,413 Reduced 5.14%
26,080 $3.02 Million
Q1 2021

Apr 23, 2021

BUY
$108.84 - $128.23 $370,164 - $436,110
3,401 Added 14.12%
27,493 $3.3 Million
Q4 2020

Feb 02, 2021

SELL
$105.0 - $114.42 $210 - $228
-2 Reduced 0.01%
24,092 $2.64 Million
Q3 2020

Oct 27, 2020

BUY
$91.64 - $111.29 $398,908 - $484,445
4,353 Added 22.05%
24,094 $2.62 Million
Q2 2020

Jul 16, 2020

SELL
$76.57 - $98.0 $153,905 - $196,980
-2,010 Reduced 9.24%
19,741 $1.81 Million
Q1 2020

Apr 27, 2020

BUY
$62.82 - $91.86 $274,272 - $401,060
4,366 Added 25.11%
21,751 $1.72 Million
Q4 2019

Jan 30, 2020

BUY
$78.51 - $87.4 $66,262 - $73,765
844 Added 5.1%
17,385 $1.51 Million
Q3 2019

Nov 01, 2019

BUY
$81.84 - $88.74 $106,719 - $115,716
1,304 Added 8.56%
16,541 $1.38 Million
Q2 2019

Aug 05, 2019

SELL
$72.88 - $85.0 $27,184 - $31,705
-373 Reduced 2.39%
15,237 $1.28 Million
Q1 2019

May 01, 2019

SELL
$66.22 - $80.06 $3,642 - $4,403
-55 Reduced 0.35%
15,610 $1.25 Million
Q4 2018

Feb 05, 2019

BUY
$65.56 - $74.27 $50,546 - $57,262
771 Added 5.18%
15,665 $1.13 Million
Q3 2018

Nov 01, 2018

BUY
$60.81 - $73.36 $80,694 - $97,348
1,327 Added 9.78%
14,894 $1.09 Million
Q2 2018

Jul 30, 2018

BUY
$57.57 - $63.54 $56,015 - $61,824
973 Added 7.73%
13,567 $827,000
Q1 2018

May 08, 2018

BUY
$56.27 - $63.62 $7,090 - $8,016
126 Added 1.01%
12,594 $755,000
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $15,996 - $17,126
-298 Reduced 2.33%
12,468 $712,000
Q3 2017

Nov 15, 2017

BUY
$48.06 - $53.64 $613,533 - $684,768
12,766 New
12,766 $706,000
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $607,862 - $678,438
-12,648 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
12,648
12,648 $622,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.